OncoSec Medical Inc (ONCSQ)

[furbush87]

I have two thoughts on that, If the trial size is 60-100, then I can't imagine they are planning on seeking approval after this trial is over. If the trial size is closer to 150, that would be a big indicator to me that they are hoping to get approved off of this trial.
Merck is likely taking care of any costs related to Keytruda, so ONCS should have limited costs, UCSF is likely paying for staff salaries, with a small fee for facilities and other items. This should be cheaper than ONCS doing it themselves, and probably equivalent in costs to the 3 trials ONCS currently has (MCC 15pateints T-Cell 15 patients, Melanoma 30 patients)